Multicentre dosimetry study of mantle treatment in Australia and New Zealand

Radiotherapy and Oncology

Volumn 40, Issue 2, 1996, Pages 171-180

  Amies, Chris ^a   Rose, Alex ^a   Metcalfe, Peter ^b   Barton, Michael ^c  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b Illawarra Cancer Care Centre   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Hodgkin's disease; Multicentre study; Phantom; Quality assurance; Thermoluminescence

Indexed keywords

ARTICLE; AUSTRALIA; CANCER RADIOTHERAPY; CONTROLLED STUDY; DOSIMETRY; HODGKIN DISEASE; HUMAN; MULTICENTER STUDY; NEW ZEALAND; PHANTOM; PRIORITY JOURNAL; QUALITY CONTROL; THERMOLUMINESCENCE;

EID: 0030220291     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-8140(96)01779-3     Document Type: Article

References (27)

1. [1] Barton, M., Boyages, J., Crennan, E., Davis, S., Fisher, R.J., Hook, C., Johnson, N., Joseph, D., Liew, K.H., Morgan, G., O'Brien, P., Pendlebury, S., Pratt, G., Quong, G., Thornton, D., Trotter, G., Walker, Q. and Wallington, M. Radiation therapy for early stage Hodgkin's disease: Australasian patterns of care. Int. J. Radiat. Oncol. Biol. Phys. 31: 227-236, 1995.
2. [2] Carmel, R.J. and Kaplan, H.S. Mantle irradiation in Hodgkin's disease. Cancer 37: 2813-2825, 1976.
3. [3] Cilliers, G.D., Cilliers, C. and Browde, S. A study of the mantle technique for Hodgkin's disease using thermoluminescent dosimetry. Radiother. Oncol. 10: 321-326, 1987.
4. [4] Constantinou, C., Attix, F.H. and Paliwal, B. A solid water phantom material for radiotherapy X-ray and gamma-ray beam calibrations. Med. Phys. 9: 436-441, 1982.
5. [5] Cunningham, J.R., Shrivatava, P.N. and Wilkinson, J.M. Program - IRREG - Calculation of dose from irregularly shaped radiation beams. J. Comput. Programs Biomed. 2: 192-199, 1972.
6. [6] Fowler, J.F. The linear-quadratic formula and progresss in fractionated radiotherapy. Br. J. Radiol. 62: 679-694, 1989.
7. [7] Gaspodorowicz, M.K., Sutcliffe, S.B., Bergsagel, F. and Chua, T. Radiation therapy in clinical stage I and II Hodgkin's disease. Eur. J. Cancer 28: 1841-1846, 1992.
8. [8] Gray, L. and Prosnitz, L.R. Dosimetry of Hodgkin's disease therapy using a 4 MV linear accelerator. Radiology 116: 423-428, 1975.
9. [9] Hallberg, J.P. Concepts and accuracy of an improved irregular fields dosimetry computer program. MSc Thesis, University of Colorado Medical Centre, 1976.
10. [10] Haybittle, J.L., Easterling, M.J., Bennett, M.H., Vauhan, L., Hudson, B. and MacClennan, K.A. Review of British national lymphoma investigation studies of Hodgkin's disease and development of prognostic index. Lancet 967-972, 1985.
11. [11] Hellman, S. Pathologic stages 1A and 11A Hodgkin's disease: results of treatment with radiotherapy alone, 1968-1980. J. Clin. Oncol. 3: 749-750, 1985.
12. [12] IAEA. Absorbed dose determination in photon and electron beams. An international code of practice. IAEA Technical Report Series Number 277, 1987.
13. [13] International Commision on Radiological Units. Determination of absorbed dose in a patient irradiated with beams of X-or gamma-rays in radiation procedures. ICRU Report No. 24, 1976.
14. [14] Johns, H.E. and Cunningham, J.R. The Physics of Radiology, 4th edn. Charles C. Thomas, Springfield, IL, 1983.
15. [15] Kron, T., Metcalfe, P. and Wong, T. Thermoluminescence dosimetry of therapeutic X-rays with LiF ribbons and rods. Phys. Med. Biol. 38: 833-845, 1993.
16. [16] Khan, F. Dosimetry of irregularly shaped fields. In: Levitt and Tapley's Technological Basis of Radiation Therapy: Practical Clinical Applications, 2nd edn., Chapter 7, pp. 73-79. Editors: S.H. Levitt, F.M. Khan and R.A. Potish. Lea & Febiger, Philadelphia, 1992.
17. [17] Mackie, T.R., Scrimger, J.W. and Battista, J.J. A convolution method of calculating dose for 15 MV X-rays. Med. Phys. 12: 188-196, 1985.
18. [18] Metcalfe, P.E., Kron, T., Elliott, A., Wong, T.P.Y. and Hoban, P.W. Dosimetry of 6-MV beam penumbra. Med. Phys. 20: 1439-1445, 1993.
19. [19] Metcalfe, P.E., Wong, T.P.Y. and Hoban, P.W. Radiotherapy X-ray beam inhomogeneity corrections: the problem of lateral electronic disequilibrium in lung. Aust. Phys. Eng. Sci. Med. 16: 155-168, 1993.
20. [20] National Radiation Laboratories of New Zealand. Absorbed dose determination in photon and electron beams: an adaptation of the IAEA international code of practice. NRL Publication No. 0-477-04563-4, 1989.
21. [21] Pijpelink, J. and van den Tempel, K. A pencil beam algorithm for photon beam calculations. Nucletron-Oldelft Activity 6: 21-32, 1995.
22. [22] Sontag, M.R. and Cunningham, J.R. The equivalent tissue-air-ratio method for making absorbed dose calculations in a heterogeneous medium. Radiology 129: 787-794, 1978.
23. [23] Svahn-Tapper, G. and Landberg, T. Mantle treatment of Hodgkin's disease with Cobalt-60. Acta Radiol. Ther. Phys. Biol. 10: 33-55, 1971.
24. [24] Thames, H.D. and Hendry, J.H. Fractionation in Radiotherapy. Taylor & Francis, London, 1987.
25. [25] Van Dyk, J. Lung dose calculations using computed tomography: is there a need for pixel-based procedures. Int. J. Radiat. Oncol. Biol. Phys. 9: 1035-1041, 1983.
26. [26] Van Dyk, J., Battista, J.J. and Rider, W.D. The use of computed tomography in lung dose calculations for upper half-body irradiations. Br. J. Radiol. 15: 90-97, 1979.
27. [27] White, D.R., Constantinou, C. and Martin, R.J. Foamed epoxy resin-based lung substitutes. Br. J. Radiol. 59: 787-790, 1986.